Comments
Hyderabad-based Vanta Bioscience , which is in the business of pre-clinical services, announced its foray into clinical research through a 100 per cent subsidiary. The clinical research business will begin contributing to the topline in the last quarter of the current financial year, it said in a statement. The company is projecting to add revenue of ₹250 crore in the fifth year through clinical research services. Major activities covered under clinical services include bio-equivalence studies in healthy human volunteers, patient volunteers, bioanalytical services and clinical trials from Phase I to Phase IV. Shares of Vanta Bioscience gained 3.77 per cent at ₹84.05.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.